Universe Pharmaceuticals INC now has a reported 18.3% ownership position held by Origin Force Intelligence Limited, equal to 916,759 Class A ordinary shares. The position matters to investors because the reporting persons said the securities were not acquired or held to change or influence control of Universe Pharmaceuticals.

Key Highlights

  • Origin Force Intelligence Limited reported 18.3% ownership of Universe Pharmaceuticals.
  • The reported position consists of 916,759 Class A ordinary shares.
  • The Schedule 13G identifies the ownership as passive under Rule 13d-1(c).

The ownership position is described as passive under Rule 13d-1(c), with the securities not acquired or held to change or influence control of Universe Pharmaceuticals (NASDAQ: UPC).

The documents list Universe Pharmaceuticals INC (NASDAQ: UPC) as a Cayman Islands exempted company with an address in Ji'an, Jiangxi, China.

Passive Status Limits Stated Control Purpose

The reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing Universe Pharmaceuticals’ control. They also said the position was not held in connection with a transaction having that purpose, other than activities solely connected with a nomination under the cited rule.